Home / Resources / Disasters Averted / ISMP: Eli Lilly Working to Decrease Humulin R U-500 Errors

ISMP: Eli Lilly Working to Decrease Humulin R U-500 Errors

Apr 21, 2014

From the Institute for Safe Medication Practices (ISMP): Insulin errors are number #1 on the list of drugs with the most errors. A major cause for that is the use of U500 insulin. Because of that, Eli Lilly is developing a new way to inject U500 insulin to help prevent errors. Lilly is working to develop a prefilled pen designed to deliver Humulin R U-500 (insulin human), and the company is also working with a development partner on the design of a dedicated U-500 insulin syringe….

These dedicated devices, if approved, will allow administration of HumulinR U-500 in actual units without dose conversion to non-dedicated syringe markings (unit markings with a U-100 insulin syringe or volume [mL] markings with a volumetric syringe).

Due to the complexity and risks inherent in device development and regulatory review, the company is unable to speculate on the timing of availability of these devices. Until then, HumulinR U-500 must be administered using a U-100 insulin syringe or a volumetric (tuberculin or allergy) syringe.

Preventing U500 Insulin errors:

ISMP is receiving an increased number of reports of medication mix-ups involving prescriptions for regular insulin U-500 and insulin U-100. Prescribers have sometimes selected U-500 regular insulin in error from selection screens of electronic prescribing systems instead of U-100 insulin. The errors seem to be related to the position of insulin product listings on computer screens. For example, "Humulin R Injection Solution 100 UNITS/ML" might be one line apart from "Humulin R Injection Solution 500 UNITS/ML." Also, depending on the screen size, the entire line, particularly the drug concentration, may not be visible. These factors make it easy for the prescriber to see only the first few words of the product listing. Also, since U-500 use is not common, prescribers may not look for information about concentration if they believe insulin is available only in a U-100 concentration. However, the use of U-500 insulin may be increasing due to the obesity epidemic, increased insulin resistance, use in insulin pumps, and prescriber’s use of tight glucose control protocols. ISMP has contacted the major drug information system providers, Multum, First DataBank and Medi-Span, and each agreed to add the word "concentrated" immediately following the drug name and preceding U-500.

Depending on which system your computer uses, you should begin seeing the new listings in vendor updates now. If you control how drugs are listed in inventory screens in your setting, consider this change for your system. If U-500 insulin is not commonly used, consider listing it differently than other insulins so that it doesn’t appear on the screen with other insulin products. Adding a hard stop to all U-500 insulin orders — which requires prescribers and pharmacists to verify that the concentrated strength is intended for the patient — can also help prevent errors. Finally, if you do not have any patients who need U-500, don’t stock it. That alone can decrease the potential for dispensing errors.  

Diabetes in Control would like to acknowledge the Institute for Safe Medication Practices’ outstanding work in medication safety, including the above excerpt. For more information on this issue as well as other important safety issues, please visit ISMP.org.

Report Medication Errors to ISMP:

Diabetes in Control is partnered with the Institute for Safe Medication Practices (ISMP) to help ensure errors and near-miss events get reported and shared with millions of health care practitioners. The ISMP is a Patient Safety Organization obligated by law to maintain the anonymity of anyone involved, as well as omitting or changing contextual details for that purpose. Help save lives and protect patients and colleagues by confidentially reporting errors to the ISMP.



And if you have a "Diabetes Disaster Averted" story, please also send it in separately to Diabetes In Control. If we use it you will receive a Visa Gift Card worth $25.00. Click here to let us know the details. (You can use your name or remain anonymous if you prefer.) Please note that ISMP is not associated with this Gift Card promotion.